Alpha Wave Global, LP Omeros Corp Transaction History

Alpha Wave Global, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.67 - $8.54 $1.91 Million - $2.88 Million	-337,197 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$13.4 - $16.3 $134,241 - $163,293	-10,018 Reduced 2.89%	337,197 $4.65 Million
Q2 2021 Aug 13, 2021	SELL	$14.81 - $19.13 $212,153 - $274,037	-14,325 Reduced 3.96%	347,215 $5.15 Million
Q1 2021 May 17, 2021	BUY	$14.52 - $23.53 $5.25 Million - $8.51 Million	361,540 New	361,540 $6.44 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Alpha Wave Global, LP, based on Form 13F filings with the SEC.

Stay updated on Alpha Wave Global, LP with notifications on news.